Search - tctmd.com

Displaying 981 - 1000 of 2043

Sort: Relevancy | Date

Site Investigators Missed Clinical Events in GLOBAL LEADERS

News Daily News

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Michael O'Riordan

February 12, 2021

FDA Approves Evinacumab for Rare Homozygous FH

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

February 08, 2021

COVID-19: TCTMD’s Daily Dispatch for February Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for February Week 2

February 08, 2021

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

Did Regional Differences Muddy Results in COMMANDER-HF?

News Daily News

Did Regional Differences Muddy Results in COMMANDER-HF?

February 04, 2021

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

News Daily News

Afternoon Blahs? Statin Prescriptions More Likely for Early-Day Patients

Michael O'Riordan

February 01, 2021

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

News Daily News

Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups

February 01, 2021

February 2021 News Roundup

News Opinion CV Team Dispatch

February 2021 News Roundup

February 01, 2021

Despite COVID-19 Heart Disease Remains Top US Killer AHA (1).jpeg

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

News Daily News

Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD

Michael O'Riordan

January 25, 2021

New Advanced Training Outlined for Future Vascular Medicine Specialists

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

FDA Approves Vericiguat for High-risk Patients With HF

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

News Daily News

CAC Screening Cost-effective for Statin Decisions in Hereditary CAD

Michael O'Riordan

January 14, 2021

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

News Daily News

REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients

January 13, 2021

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

January 11, 2021

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

January 2021 News Roundup

News Opinion CV Team Dispatch

January 2021 News Roundup

January 01, 2021

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

December 24, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.